Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial

Zhang, 2022, The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron, Emerg Microbes Infect, 11, 1, 10.1080/22221751.2021.2017757 Pérez-Then, 2022, Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination, Nat Med, 28, 481, 10.1038/s41591-022-01705-6 Cai, 2022, Modeling transmission of SARS-CoV-2 Omicron in China, Nat Med, 1468, 10.1038/s41591-022-01855-7 W.H.O. Coronavirus, (COVID-19) dashboard. https://covid19.who.int/. Accessed February 24, 2023. Miller, 2020, Disease and healthcare burden of COVID-19 in the United States, Nat Med, 26, 1212, 10.1038/s41591-020-0952-y Yang, 2020, Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China, Nat Commun, 11, 5411, 10.1038/s41467-020-19238-2 Food and Drug Administration, Drugs.https://www.fda.gov/media/155050/download, Accessed September 14, 2022. Ren, 2020, Traditional Chinese medicine for COVID-19 treatment, Pharmacol Res, 155 Li, 2020, The role played by traditional Chinese medicine in preventing and treating COVID-19 in China, Front Med, 14, 681, 10.1007/s11684-020-0801-x National Health Commission of the People's Republic of China. Diagnosis and treatment protocol for COVID-19 (Trial Version 9.0). http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba44, Accessed September 12, 2022. Accessed September 14, 2022. Zheng, 2002 Yang, 2020, Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study, Pharmacol Res, 157, 10.1016/j.phrs.2020.104820 Li, 2004, [Clinical observation on treatment of SARS with combination of chaihu droplet pill and huoxiang zhengqi droplet pill], Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 321 Zhang, 2020, The important role of volatile components from a traditional chinese medicine Dayuan-Yin against the COVID-19 pandemic, Front Pharmacol, 11 Ni, 2020, Combating COVID-19 with integrated traditional Chinese and Western medicine in China, Acta Pharm Sin B, 10, 1149, 10.1016/j.apsb.2020.06.009 Luo, 2020, Analysis of influencing factors of death in patients with COVID-19, Chin Tradit Herb Drugs, 51, 1450 Wang, 2021, Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: a retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. J Ethnopharmacol, 277 Shi, 2021, Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial, Phytomedicine, 81, 10.1016/j.phymed.2020.153367 Brodin, 2021, Immune determinants of COVID-19 disease presentation and severity, Nat Med, 27, 28, 10.1038/s41591-020-01202-8 Lyra, 2022, Inflammation at the crossroads of COVID-19, cognitive deficits and depression, Neuropharmacology, 209 Liu, 2021, Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): a single-center, open-label, randomized controlled trial, Phytomedicine, 91, 10.1016/j.phymed.2021.153671 Anantharaj, 2022, Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses, J Clin Virol, 146, 10.1016/j.jcv.2021.105060 Toor, 2021, T-cell responses and therapies against SARS-CoV-2 infection, Immunology, 162, 30, 10.1111/imm.13262 Hosseini, 2020, Innate and adaptive immune responses against coronavirus, Biomed Pharmacother, 132, 10.1016/j.biopha.2020.110859 Wei, 2021, Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS, Chin J Nat Med, 19, 473 Burkard, 2017, Dietary flavonoids and modulation of natural killer cells: implications in malignant and viral diseases, J Nutr Biochem, 46, 1, 10.1016/j.jnutbio.2017.01.006 Silva, 2021, A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity, Sci Immunol, 6, 1152, 10.1126/sciimmunol.abf1152 Chen, 2020, Astragali Radix (Huangqi): a promising edible immunomodulatory herbal medicine, J Ethnopharmacol, 258, 10.1016/j.jep.2020.112895 Brendler, 2021, Botanical drugs and supplements affecting the immune response in the time of COVID-19: implications for research and clinical practice, Phytother Res, 35, 3013, 10.1002/ptr.7008 Kallon, 2013, Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo, J Anim Sci Biotechnol, 4, 22, 10.1186/2049-1891-4-22 Wu, 2016, Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines, Int J Biol Macromol, 91, 248, 10.1016/j.ijbiomac.2016.05.046